Skip to main content
LIVN
NASDAQ Industrial Applications And Services

Shareholders Approve Significant Share Issuance Authority and 10% Buyback Program

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$79.01
Mkt Cap
$4.34B
52W Low
$41.015
52W High
$79.38
52W Position info
93% above low
Off High info
at 52W high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

LIVN sits 93% above its 52-week low of $41.015 on light trading volume (0.1× avg).

Summary

LivaNova shareholders approved both a substantial share issuance authority (up to 20% of market cap) and a significant share repurchase program (up to 10% of shares), providing the company with considerable capital management flexibility.


Key Events · Financing and Capital Events · LIVN

  • Share Allotment Authority Approved

    Shareholders authorized directors to allot shares and grant rights to subscribe for shares up to an aggregate nominal amount of £10,985,296, which represents approximately 20% of the current market capitalization. This provides significant capital-raising capacity but also potential dilution.

  • Disapplication of Pre-emption Rights Approved

    Shareholders empowered directors to allot equity securities for cash without offering them to existing shareholders first, up to the same nominal amount of £10,985,296. This streamlines future capital raises.

  • Share Repurchase Program Approved

    The company is authorized to repurchase up to 10% of its total issued Ordinary Shares. This program, approved while the stock trades near its 52-week high, indicates management's confidence in the company's valuation.

  • All Directors Re-elected

    All eleven nominated directors were re-elected for a term expiring at the 2027 Annual General Meeting with strong shareholder support.


Analysis · LIVN · Industrial Applications And Services

LivaNova shareholders approved significant capital management flexibility, authorizing directors to issue new shares up to approximately 20% of the current market capitalization and simultaneously approving a share repurchase program for up to 10% of outstanding shares. While the share issuance provides substantial capital-raising capacity, it also introduces potential dilution. The approval of a significant buyback program, especially with the stock trading near its 52-week high, signals management's confidence in the company's valuation and could provide support for the share price.

At the time of this filing, LIVN was trading at $79.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $41.02 to $79.38. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LIVN - Latest Insights

LIVN
Jun 16, 2026, 12:58 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $80.64
Real-time Price: $78.19 info
Change: -$2.45 (-3%) info
Market Cap: $4.295B info
LIVN
May 06, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $57.70
Real-time Price: $78.19 info
Change: +$20.49 (+36%) info
Market Cap: $4.295B info
LIVN
May 06, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $57.70
Real-time Price: $78.19 info
Change: +$20.49 (+36%) info
Market Cap: $4.295B info
LIVN
Apr 29, 2026, 8:30 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $61.41
Real-time Price: $78.19 info
Change: +$16.78 (+27%) info
Market Cap: $4.295B info
LIVN
Feb 25, 2026, 3:26 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $70.36
Real-time Price: $78.19 info
Change: +$7.83 (+11%) info
Market Cap: $4.295B info